X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (29) 29
female (18) 18
male (18) 18
oncology (18) 18
middle aged (17) 17
hematology (16) 16
adult (14) 14
aged (14) 14
treatment outcome (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
cancer (9) 9
lymphomas (9) 9
phase-ii (9) 9
chemotherapy (8) 8
prognosis (8) 8
abridged index medicus (7) 7
aged, 80 and over (7) 7
myc (7) 7
non-hodgkin lymphoma (7) 7
rituximab (7) 7
young adult (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
article (6) 6
b-cell lymphoma (6) 6
care and treatment (6) 6
lymphoma (6) 6
transplantation (6) 6
analysis (5) 5
expression (5) 5
hemic and lymphatic diseases (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
neoplasm staging (5) 5
remission induction (5) 5
research (5) 5
retrospective studies (5) 5
survival analysis (5) 5
antineoplastic agents - therapeutic use (4) 4
bcl2 (4) 4
biomarkers (4) 4
cyclophosphamide - therapeutic use (4) 4
disease-free survival (4) 4
doxorubicin - therapeutic use (4) 4
follow-up (4) 4
lymphoma, b-cell - genetics (4) 4
lymphoma, large b-cell, diffuse - pathology (4) 4
multivariate analysis (4) 4
patient outcomes (4) 4
prednisone - therapeutic use (4) 4
risk factors (4) 4
salvage therapy (4) 4
stem cell transplantation (4) 4
stem cells (4) 4
survival (4) 4
survival rate (4) 4
therapy (4) 4
usage (4) 4
vincristine - therapeutic use (4) 4
allergy and immunology (3) 3
animals (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antineoplastic agents - adverse effects (3) 3
biomarkers, tumor - genetics (3) 3
cell differentiation (3) 3
chronic lymphocytic-leukemia (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
diagnosis (3) 3
disease (3) 3
dna-binding proteins - genetics (3) 3
etoposide (3) 3
etoposide - therapeutic use (3) 3
gene rearrangement (3) 3
health aspects (3) 3
hodgkin disease - drug therapy (3) 3
immune system diseases (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
lymphoma, non-hodgkin - diagnosis (3) 3
lymphoma, non-hodgkin - pathology (3) 3
non-hodgkin's lymphomas (3) 3
non-hodgkins-lymphoma (3) 3
non‐hodgkin lymphoma (3) 3
phase-ii trial (3) 3
poor-prognosis (3) 3
prednisone (3) 3
prognostic-factors (3) 3
recurrence (3) 3
rituximab - administration & dosage (3) 3
rituximab plus cyclophosphamide (3) 3
skin (3) 3
stem cell transplant (3) 3
transplantation, autologous (3) 3
vincristine (3) 3
acquired immune deficiency syndrome (2) 2
active antiretroviral therapy (2) 2
adolescent (2) 2
aggressive lymphoma (2) 2
anthracyclines (2) 2
antineoplastic combined chemotherapy protocols (2) 2
b-cell (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3990 - 3990
Background: MCL carries a poor overall prognosis despite high response rates to induction chemotherapy. Maintenance strategies have impacted survival in MCL... 
Journal Article
Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 24, pp. 3884 - 3895
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4147 - 4147
Abstract Background: mTOR inhibitors, including temsirolimus (TEM), have demonstrated activity in patients (pts) with relapsed/refractory (rel/ref) lymphomas... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2737 - 2737
Abstract Introduction: Post-transplant lymphoproliferative disease (PTLD) encompasses a heterogeneous array of cases of lymphoma/lymphoma-like conditions... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 4264 - 4264
Abstract Abstract 4264 Background: Recent reports have suggested an increase in the incidence of T-cell lymphoma (TCL) in the United States. Despite newer... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 640 - 640
Abstract Background DHL are high-grade B-cell lymphomas (BCL) characterized by dual gene rearrangements (RA) of MYC and either BCL2 or BCL6. Outcomes are... 
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 15, pp. 2354 - 2361
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a... 
REARRANGEMENT | SURVIVAL | TRANSLOCATION | POOR-PROGNOSIS | RITUXIMAB | MYC | PHASE-II | GERMINAL CENTER | INDEX | HEMATOLOGY | EXPRESSION | Multivariate Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Remission Induction | Stem Cell Transplantation | Young Adult | Disease-Free Survival | Lymphoma - therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB232 - AB232
  [...]BAT responses to a non-IgE-dependent stimulus, formyl-methionyl-leucyl-phenylalanine, were unaffected or minimally altered. 
Allergy and Immunology | Medical colleges | Medical tests | Usage | Cancer patients | Skin | Drug therapy | Allergies
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2017, Volume 140, Issue 3, pp. 875 - 879.e1
Tyrosine kinases, including Bruton's tyrosine kinase (BTK), have been shown to be critical for allergen reactivity by transducing Fc[epsilon]RI crosslinking... 
Allergy and Immunology | Tyrosine | Food allergies | Leukemia | Immunoproliferative diseases | Asthma | Studies | Anaphylaxis | Lymphocytes | Skin | Lymphomas | Protein-tyrosine kinase | Drug dosages | Skin tests
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 436 - 436
Abstract Abstract 436 mTOR inhibitors have been used with clinical success in solid tumors and non-Hodgkin lymphoma (NHL), and are attractive therapeutic... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2016, Volume 175, Issue 4, pp. 631 - 640
Summary Rearrangement of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma (DLBCL) and B cell lymphoma unclassifiable... 
fluorescence in situ hybridization | B cell lymphoma unclassifiable | diffuse large B cell lymphoma | chemotherapy | MYC | SURVIVAL | TRANSLOCATION | IMMUNOCHEMOTHERAPY | R-CHOP | CLASSIFICATION | TRANSPLANTATION | IMPACT | fluorescence insitu hybridization | BURKITT-LYMPHOMA | FEATURES INTERMEDIATE | HEMATOLOGY | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Genes, myc | Lymphoma, B-Cell - genetics | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, B-Cell - mortality | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Proportional Hazards Models | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Gene Rearrangement | Vincristine - therapeutic use | Biomarkers | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphomas | Gene amplification | B cell lymphoma | CHEMOTHERAPY | Gene rearrangement
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3924 - 3924
Background: Apoptotic cell death can be triggered by activation of extrinsic and intrinsic signaling pathways. Tumor necrosis factor (TNF)-related... 
Journal Article
Blood, ISSN 0006-4971, 2019, Volume 133, Issue 18, pp. 1964 - 1976
Novel strategies, such as chemosensitization with targeted agents, that build on the success of standard immunochemotherapy show promise for the treatment of... 
B-CELL LYMPHOMA | PROGNOSTIC IMPACT | RITUXIMAB | MYC | BCL2 | HEMATOLOGY | EXPRESSION | Clinical Trials and Observations
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 778 - 783
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1500 - 1500
Abstract Background: Central nervous system (CNS) relapse in pts with aggressive non-Hodgkin lymphoma (NHL) is a generally fatal complication, with median... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.